Growth Metrics

West Pharmaceutical Services (WST) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.11.

  • West Pharmaceutical Services' FCF Payout Ratio fell 2316.04% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year decrease of 1212.74%. This contributed to the annual value of 0.21 for FY2024, which is 5548.88% up from last year.
  • Per West Pharmaceutical Services' latest filing, its FCF Payout Ratio stood at 0.11 for Q3 2025, which was down 2316.04% from 0.15 recorded in Q2 2025.
  • Over the past 5 years, West Pharmaceutical Services' FCF Payout Ratio peaked at 0.53 during Q1 2024, and registered a low of 0.1 during Q3 2021.
  • In the last 5 years, West Pharmaceutical Services' FCF Payout Ratio had a median value of 0.15 in 2025 and averaged 0.18.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first plummeted by 5765.96% in 2022, then skyrocketed by 11153.25% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' FCF Payout Ratio (Quarter) stood at 0.16 in 2021, then tumbled by 34.24% to 0.1 in 2022, then grew by 9.39% to 0.11 in 2023, then soared by 58.22% to 0.18 in 2024, then tumbled by 37.2% to 0.11 in 2025.
  • Its FCF Payout Ratio stands at 0.11 for Q3 2025, versus 0.15 for Q2 2025 and 0.26 for Q1 2025.